In addition, it was found that IL-2 significantly decreased the expression of the inhibitory receptor CTLA-4 and increased the expression of B lymphocyte-induced maturation protein-1(Blimp-1), leading to the activation of effector T cells and the induction apoptosis of the breast tumor cells. Here, PRDM1 is linked to breast neoplasm.